Off-hours Primary PCI Still Have the Highest Mortality Rate?

According to this contemporary study, in the current organized STEMI network, patients admitted to a tertiary high-volume center for primary PCI are managed similarly and have similar prognosis regardless admission time. 

¿Las angioplastias primarias a la madrugada siguen teniendo mayor mortalidad?

Several prior studies have shown primary PCI during off-hours (6 pm to 8 am) had worse outcomes vs. on-hour interventions (8 am to 6 pm). Something similar occurred when comparing weekend and holiday outcomes vs. working days. 

This study analyzed the outcomes of 2167 consecutive STEMI patients admitted to a tertiary primary PCI center 24 hours, 7 days a week, all year round.


Read also: Net Benefit of Left Atrial Appendage Closure vs. Anticoagulation in Atrial Fibrillation.


1048 patients (48.3%) were admitted on-hours and 1119 (51.7%) off-hours.

Baseline clinical characteristics were well balanced between the groups, including cardiac arrest rate (7.9% vs 8.8%) and cardiogenic shock (12.3% vs 14.7%).

Mean time between symptom onset and fist medical contact and mean time between first contact and sheath insertion resulted similar between both groups (120 min vs. 126 min; p=0.25 y 90 min vs. 93 min; p=0.58, respectively), same as radial access rate (85.6% vs. 87.5%; p=0.27).


Read also: International Consensus to Prevent Radial Artery Occlusion After Interventions.


There was no association between time and procedure and in-hospital mortality (8.1% vs. 7.0%; p=0.49) and mortality at one year (11.0% vs. 11.1%; p=0.89).

Conclusion

The contemporary organized STEMI network has successfully beaten the myth of worse off hours PCI prognosis. This was true for both in-hospital mortality and one year mortality, at least for one high volume tertiary center. 

Original title: On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.

Reference: Benoit Lattuca et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....